A tiny antibody component could fundamentally transform the treatment of cystic fibrosis: For the first time, researchers ...
A tiny antibody component could fundamentally transform the treatment of cystic fibrosis: For the first time, researchers ...
A new study from The Hospital for Sick Children (SickKids) reveals the process underlying protein organization on cell membranes, a finding which could pave the way for innovative cystic fibrosis ...
Cystic fibrosis is a genetic disease that causes serious and sometimes fatal respiratory and digestive disorders. A new treatment, available since 2020, improves lung function and quality of life.
Cystic fibrosis (CF) remains an exemplar of how detailed molecular understanding can fuel transformative advances in treatment. Research in this field spans elucidating the genetic and cellular ...
Office was a generous word for the room in which Dr. Mike Welsh did lots of his research. Large closet fits better. Welsh was mostly alone, hunched over specialized microscopic equipment on a ...
Alyftrek (vanzacaftor/tezacaftor/deutivacaftor) is a combination medicine approved by the FDA in 2024. Alyftrek is approved to treat people ages 6 and older who have ...
Atypical cystic fibrosis is a mild form of cystic fibrosis. People with this type of cystic fibrosis can experience symptoms that come and go or that are less severe than those people with classic ...
Cystic fibrosis (CF) is a disease that people can be born with. While there is no cure, people with CF may live well into adulthood if they receive the appropriate treatment and medical monitoring.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results